Immunex, Wyeth-Ayerst Pharmaceuticals regulatory update

By WIR Staff | Nov 9, 1998 | 8:00 AM GMT

The FDA approved IMNX's Enbrel etanercept to treat moderately to severely active rheumatoid arthritis in

Read the full 157 word article

How to gain access

Continue reading with a
two-week free trial.